A fixed-dose combination (FDC) medication primarily used in the Indian market for the symptomatic treatment of allergic respiratory conditions complicated by thick mucus and potential parasitic (filarial) involvement. Bromhexine is a mucolytic, Cetirizine is a second-generation antihistamine, and Diethylcarbamazine (DEC) is an anti-filarial agent. This combination is specifically formulated for conditions where allergy, bronchospasm, and filarial infection may co-exist or present with overlapping symptoms, such as Tropical Pulmonary Eosinophilia (TPE).
One tablet twice daily after meals. The exact DEC dose must be verified; common strengths are 50mg or 100mg of DEC per tablet.